share_log

摩根大通售出药明生物(02269.HK)4,231.87万股普通股股份,价值约6.13亿港元

J.P. Morgan sold 42,318,700 common shares of Pharmaceutical Biotech (02269.HK) worth approximately HK$613 million

Futu News ·  May 22 17:04

On May 22, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 22, JPMorgan Chase & Co. (JPMorgan Chase & Co.) sold on May 16 at an average price of HK$14.495 per share on the market and an average price of HK$14.4931 per share outside the market$WUXI BIO (02269.HK)$42,318,700 common shares worth approximately HK$613 million. After the sale, J.P. Morgan Chase's latest shareholding was 213 million shares, and the good position ratio dropped from 5.98% to 4.99%.

Additional Information: JP Morgan Chase & Co. Cricket to have a no-tiring interest in the shares.

HKEXAutoNews_CS20240521E00490.png

What is disclosure of interests?

As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. The directors and top executives of a listed company must disclose their interest in shares and debentures of the listed company and the company linked to the listed company.

Why is disclosure of interests important?

Disclosure of interests allows investors to identify (1) persons who control or are capable of controlling the stock interests of listed companies, and (2) persons who may benefit from transactions involving linked entities of listed companies.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment